Technologies

The technology, developed by CNR-ICB, is based on an innovative bioprocess called "Caphnophilic (CO2-requiring) Lactic Fermentation (CLF)”, developed in the hyperthermophilic bacterium Thermotoga neapolitana (EP patent: EP2948556B1), which allows the production of "green" hydrogen and capture and valorization of CO2 in L -lactic acid (98% e.e.).

The current technology allows to achieve new macroporous superadsorbent polymeric materials able to remove toxic contaminants from water and soil showing excellent sequestering properties against arsenate As (V), chromate Cr (VI) and Borate B (III) ions. The material is obtained by radical cryopolymerization of the monomer 4'-vinyl-benzyl-N-methyl-D-glucamine and / or its mixtures with hydroxyethyl-methacrylate (HEMA).

Celiac disease and non-celiac gluten sensitivity affect a large portion of the world population. Furthermore, the percentage of people who adopt the gluten free diet is constantly increasing because it is perceived to be healthier. We have previously developed a food grade enzymatic procedure (transamidation) for wheat flour capable of making gluten unable to induce the inflammatory response in the intestine of celiac disease patients.